Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
54
Publications avec texte intégral
Open Access
46 %
Mots clés
LMNA
Immune regulation
Thymic epithelial cells
Myasthénie grave
Th17 cells
Exercise
Gender
Endogenous nucleic acids
Antimir-150
FMR1
Inflammation
Genetic associations
Disease susceptibility
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Fragile X syndromes
Immune response
BAFF
Interferon type I
Myoblasts
Etiology
CTCF
Chronicity
Immunology and Microbiology Section
Centres germinatifs ectopiques
Animal models
COX2
Immunity
Anticorps monoclonal
Experimental autoimmune myasthenia gravis
Early-onset myasthenia gravis
Chronic inflammation
Myasthenia Gravis MG
Thymus
Gd T cells
Interferon
CD31
Acetylcholine receptor antibodies
Cardiomyopathy
Chemokine
Conduction disease
Interferon IFN
Genetics
Experimental models
M3243AG
Germinal center
Inflammatory cytokines
Innate immunity
Acetylcholine receptor
Interferon type-I
Autoimmune diseases
Acides nucléiques endogènes
Ectopic germinal centers
Macrophages
Immunotherapy
Interféron de type I
B cells
Adaptive immunity
AChR antibodies
Maladie auto-immune
Human myoblasts
DICER
Interferonopathy
Thymoma
Germinal centers
Ferrites
Quality of life
Clinical cell transplantation
Il-23
Myasthenia gravis
CCL21
PBMC
Experimental autoimmune myasthenia gravis EAMG
CXCL13-CXCR5
Acetylcholine receptors
Complete Freund's adjuvant
MiR-125
MYB
MiR-7
Autoimmunity
Cytokines
Neuromuscular junction
MG patients
Transcriptome
Chemokines
Experimental mouse models
Glucocorticoids
Interferon-β
COVID-19
Long-term follow-up
Interleukine-23
Auto-immunité
Heart failure
Autoimmune disease
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Cellules th17
Mass cytometry CyTOF
Max
Interferon de type I
Lamin A/C nuclei
Interleukin 23